EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ELF4/TRIB3/CDK6 Axis Promotes Cancer Stem Cell Activity in Endometrial Cancer

Chun-Yu Chen, Yueh-Chun Lee, Yu-Hao Huang, Wen-Ling Wang, Wen-Wei Chang iD

Journal of Cellular Physiology · 2025

DOI: 10.1002/jcp.70113 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular Physiology, 2025. Verfasst von Chun-Yu Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan. Hauptthemen laut MEDLINE: Endometrial Neoplasms, DNA-Binding Proteins, Transcription Factors, Neoplastic Stem Cells. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was supported by the National Science and Technology Council in Taiwan (to WWC, grant numbers 110-2320-B-040-026, 111-2320-B-040-007-MY3, and 114-23….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endometrial cancer (EC) is the most prevalent gynecological malignancy globally. Here, we explored the role of E74‐like ETS transcription factor 4 (ELF4) in EC progression. Using the TISIDB web tool to analyze TCGA data, we found that elevated ELF4 expression correlates with higher histological grades and reduced overall survival in EC patients. Tissue microarray analysis confirmed a grade‐dependent increase in ELF4 protein levels. Knockdown of ELF4 in EC cell lines (AN3CA, HEC‐1A) and patient‐derived EC cells suppressed proliferation, cell cycle progression, and cancer stem cell (CSC) activity. Database analysis and RNA interference identified cyclin‐dependent kinase 6 (CDK6) as a downstream target of ELF4. ELF4 silencing reduced CDK6 mRNA and protein expression, while chromatin immunoprecipitation revealed direct binding of ELF4 to the CDK6 promoter. Conversely, ELF4 overexpression upregulated CDK6. Knockdown of CDK6 or treatment with the CDK4/6 inhibitor Palbociclib diminished tumorsphere formation and expression of stemness markers (OCT4, NANOG, c‐MYC) in both conventional and patient‐derived EC cells. We previously reported that the tribbles pseudokinase 3 (TRIB3)/ELF4 complex transactivates CTNNB1 expression; here, we show that TRIB3 knockdown also downregulates CDK6 at mRNA and protein levels, suggesting cooperative regulation of CDK6 by ELF4 and TRIB3. In EC specimens, ELF4, TRIB3, and CDK6 expression positively correlated, and Kaplan‐Meier analysis indicated that high co‐expression of these genes predicted the poorest overall survival. Collectively, our findings establish the ELF4/TRIB3/CDK6 axis as a critical regulator of EC progression and CSC maintenance, highlighting its potential as a therapeutic target for EC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial NeoplasmsDNA-Binding ProteinsTranscription FactorsNeoplastic Stem CellsCyclin-Dependent Kinase 6Repressor ProteinsHumansDatabases, GeneticSignal TransductionCell Line, TumorPrognosisCell ProliferationCell Cycle CheckpointsGene Expression Regulation, NeoplasticProtein Serine-Threonine KinasesCell Cycle Proteins

Stichwörter der Autor:innen

E74‐like ETS transcription factor 4cancer stem cellscyclin‐dependent kinase 6endometrial cancertribbles pseudokinase 3

Substanzen

ELF4 protein, humanDNA-Binding ProteinsTranscription FactorsCDK6 protein, humanCyclin-Dependent Kinase 6TRIB3 protein, humanRepressor ProteinsProtein Serine-Threonine KinasesCell Cycle Proteins

Autor:innen und Institutionen

  • Department of Emergency Medicine, Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan.
  • Post-Baccalaureate Medicine, National Chung Hsing University, Taichung, Taiwan.
  • Department of Radiation Oncology, Chung Shan Medical University Hospital, Taichung, Taiwan.
  • School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
  • Department of Biomedical Sciences, Chung Shan Medical University, Taichung, Taiwan.
  • Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan.

ORCID-Profile: Wen-Wei Chang

Förderung

  • This study was supported by the National Science and Technology Council in Taiwan (to WWC, grant numbers 110-2320-B-040-026, 111-2320-B-040-007-MY3, and 114-23…

Zitieren

APA

Chen, C. Y., Lee, Y. C., Huang, Y. H., Wang, W. L., & Chang, W. W. (2025). ELF4/TRIB3/CDK6 Axis Promotes Cancer Stem Cell Activity in Endometrial Cancer. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.70113

Vancouver

Chen CY, Lee YC, Huang YH, Wang WL, Chang WW. ELF4/TRIB3/CDK6 Axis Promotes Cancer Stem Cell Activity in Endometrial Cancer. Journal of Cellular Physiology. 2025. doi:10.1002/jcp.70113

BibTeX
@article{Chen2025,
  author = {Chen, Chun-Yu and Lee, Yueh-Chun and Huang, Yu-Hao and Wang, Wen-Ling and Chang, Wen-Wei},
  title = {ELF4/TRIB3/CDK6 Axis Promotes Cancer Stem Cell Activity in Endometrial Cancer},
  journal = {Journal of Cellular Physiology},
  year = {2025},
  doi = {10.1002/jcp.70113}
}
Kostenlos starten →